Add Papers Marked0
Paper checked off!

Marked works

Viewed0

Viewed works

Shopping Cart0
Paper added to shopping cart!

Shopping Cart

Register Now

internet library
Atlants.lv library
FAQ

Great deal: today with a discount!

Regular price:
2,49
You save:
0,40 (16%)
Discounted price*:
2,09
Purchase
Add to Wish List
ID number:887511
Evaluation:
Published: 19.12.2018.
Language: Latvian
Level: Secondary school
Literature: n/a
References: Not used
Time period viewed: 2016.g. - 2017.g.
Extract

Tā, 2011. gadā jaunais Grindeks medikaments Mildronāts® GX tika atzīts par „Labāko kardioloģijas medikamentu” Ukrainā,
Viens no Grindeks mērķiem ir gadā ieviest četras līdz sešas jaunas gatavo zāļu formas, kas nozīmē, ka nepārtraukti norit darbs ap 20-30 iestrādēm, kuras plāno laist tirgū piecu gadu laikā. Sekmīgi kopā apvienojot aktīvo farmaceitisko vielu un gatavo zāļu formu biznesa iespējas, Grindeks prioritāte ir vertikāli integrēti jeb pilna zāļu izstrādes un ražošanas cikla risinājumi.

Author's comment
Work pack:
GREAT DEAL buying in a pack your savings −3,07 €
Work pack Nr. 1369328
Load more similar papers

Send to email

Your name:

Enter an email address where the link will be sent:

Hi!
{Your name} suggests you to check out this Atlants.lv paper on „Uzņēmuma "Grindeks" biznesa stratēģija”.

Link to paper:
https://eng.atlants.lv/w/887511

Send

Email has been sent

Choose Authorization Method

Email & Password

Email & Password

Wrong e-mail adress or password!
Log In

Forgot your password?

Draugiem.pase
Facebook
Twitter

Not registered yet?

Register and redeem free papers!

To receive free papers from Atlants.com it is necessary to register. It's quick and will only take a few seconds.

If you have already registered, simply to access the free content.

Cancel Register